Used in the synthesis of pharmaceutical intermediates, particularly in the development of kinase inhibitors for cancer treatment. It serves as a chiral building block in asymmetric synthesis, enabling the production of enantiomerically pure active pharmaceutical ingredients. Its trifluoromethylpyridine moiety enhances metabolic stability and binding affinity in drug candidates. Commonly employed in research and development of targeted therapies for oncology and inflammatory diseases.